Diabetes and Alzheimer’s disease may share risk factors, including overlapping metabolic risk factors. Apolipoprotein E (APOE) also regulates lipid metabolism.1 This suggests that the aetiology of AD includes metabolic risk factors, which are also involved in the development of diabetes.2 Hyperglycaemia is the main characteristic of impaired glucose tolerance and diabetes,3 with evidence that hyperglycaemia is a potential risk factor for the development of cognitive dysfunction and dementia.4

Learn more about diabetes and Alzheimer’s disease

file_download Download in HQ

Related content

The Challenges and Potential of Clinical Trials in Dementia Research play_circle Video play_circle
The Challenges and Potential of Clinical Trials in Dementia Research

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

12.11.2024 Alzheimer’s Disease
image Image Stroke, migraine, AD and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Highlights from the Global Burden of Disease 2021 Study

Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021

25.07.2024 Alzheimer’s Disease
description Article
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.

09.07.2024 Alzheimer’s Disease